These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20563590)

  • 1. Patient benefit from treatment with botulinum neurotoxin A for functional indications in otorhinolaryngology.
    Braun T; Gürkov R; Hempel JM; Berghaus A; Krause E
    Eur Arch Otorhinolaryngol; 2010 Dec; 267(12):1963-7. PubMed ID: 20563590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinium toxin in ENT].
    Klap P
    Ann Otolaryngol Chir Cervicofac; 2006 Dec; 123(6):306-11. PubMed ID: 17202988
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of botulinum toxin type A in neuro-ORL].
    Périé S; Lacau St Guily J
    Ann Readapt Med Phys; 2003 Jul; 46(6):375-9. PubMed ID: 12928145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
    Blitzer A; Brin MF; Stewart CF
    Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A for treating voice tremor.
    Adler CH; Bansberg SF; Hentz JG; Ramig LO; Buder EH; Witt K; Edwards BW; Krein-Jones K; Caviness JN
    Arch Neurol; 2004 Sep; 61(9):1416-20. PubMed ID: 15364688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of oromandibular dystonia with botulinum A toxin: a series of cases.
    Teemul TA; Patel R; Kanatas A; Carter LM
    Br J Oral Maxillofac Surg; 2016 Dec; 54(10):1080-1084. PubMed ID: 27776922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laryngeal dystonia: case report and treatment with botulinum toxin.
    Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP
    Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with Botulinum Neurotoxin Improves Activities of Daily Living and Quality of Life in Patients with Upper Limb Tremor.
    Kreisler A; Bouchain B; Defebvre L; Krystkowiak P
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31413896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum neurotoxin for the treatment of movement disorders.
    Kopanidis P; Das C
    Aust J Gen Pract; 2018 Sep; 47(9):598-601. PubMed ID: 30244558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of botulinum toxin A in the treatment of gustatory sweating].
    Küttner C; Tröger M; Dempf R; Eckardt A
    Nervenarzt; 2001 Oct; 72(10):787-90. PubMed ID: 11688180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Patients Receiving Short-Interval Botulinum Toxin Chemodenervation Treatment for Laryngeal Dystonia and Essential Tremor of the Vocal Tract.
    Lagos-Villaseca A; Bhatt NK; Abdolhosseini P; Quinonez L; Paoletti MF; Gochman G; Johns MM; Rosen CA; Kao TC; Meyer TK
    JAMA Otolaryngol Head Neck Surg; 2023 Jul; 149(7):615-620. PubMed ID: 37227721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A.
    Tugnoli V; Marchese Ragona R; Eleopra R; Quatrale R; Capone JG; Pastore A; Montecucco C; De Grandis D
    Clin Auton Res; 2002 Jun; 12(3):174-8. PubMed ID: 12269549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
    Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S;
    J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.
    Nastasi L; Mostile G; Nicoletti A; Zappia M; Reggio E; Catania S
    J Neurol; 2016 Sep; 263(9):1702-8. PubMed ID: 27278063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
    Bhattacharyya N; Tarsy D
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale.
    Yoshida K
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
    Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
    Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
    Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B
    Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia.
    Lerner MZ; Lerner BA; Patel AA; Blitzer A
    Laryngoscope; 2017 May; 127(5):1131-1134. PubMed ID: 27633917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.